Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA4 | P22748 | 1/20 | 0.42 |
| ▸ | CA5A | P35218 | 1/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | ESR1 | P03372 | 1/20 | 0.40 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
| ▸ | CES1 | P23141 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | CFTR | P13569 | 1/20 | 0.38 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3995747 | 0.86 | CES2 (0.44) | CA2CA4CA5AUSP2ESR1 | |
| SCHEMBL4764636 | 0.82 | MAPT (0.40) | CA2CA4CA5AUSP2GAA | |
| SCHEMBL28239030 | 0.80 | CES2 (0.56) | CES2CES1L3MBTL1NPSR1NAPRT | |
| SCHEMBL24191888 | 0.79 | CES2 (0.48) | CA2CA4CA5AUSP2GAA | |
| SCHEMBL1827594 | 0.79 | POLB (0.46) | CA2CA4CA5AGAAKMT2A | |
| SCHEMBL4604853 | 0.76 | CES2 (0.44) | CA2CA4CA5AUSP2ESR1 | |
| SCHEMBL5190770 | 0.74 | TSHR (0.41) | CA2CA4CA5AGAAKMT2A | |
| SCHEMBL52771 | 0.74 | MEN1 (0.50) | GAAKMT2APOLBNPSR1MAPT | |
| SCHEMBL5568513 | 0.74 | CA2 (0.43) | CA2CA4CA5AUSP2GAA | |
| SCHEMBL5179990 | 0.73 | ALDH1A1 (0.59) | GAAKMT2AL3MBTL1MAPTNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 789 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1347981-B1 | CONDENSED PURINE DERIVATIVES AS A 1 ADENOSINE RECEPTOR ANTAGONISTS | BIOGEN IDEC INC (US) | 2008-05-07 | — | — | EP | claimed |
| EP-0918810-B1 | LOW TEMPERATURE CURE CARBOXYL TERMINATED POLYESTERS | RESOLUTION SPECIALTY MATERIALS (US) | 2005-03-09 | — | — | EP | claimed |
| EP-0937038-B1 | VITAMIN D ANALOGUES | LEO PHARM PROD LTD (DK) | 2002-04-17 | — | — | EP | claimed |
| JP-3109323-A | — | — | None | — | — | JP | disclosed |
| JP-2193987-A | — | — | None | — | — | JP | disclosed |
| US-12459922-B2 | PARP7 inhibitors | GILEAD SCIENCES, INC. (US) | 2025-11-04 | — | — | US | disclosed |
| US-12441683-B2 | 7-methyl indole analogs and dosage forms containing the same | Kuleon, LLC (US) | 2025-10-14 | — | — | US | disclosed |
| US-20250282722-A1 | 7-METHYL INDOLE ANALOGS AND DOSAGE FORMS CONTAINING THE SAME | KULEON LLC (US) | 2025-09-11 | — | — | US | disclosed |
| EP-4469448-A1 | PARP7 INHIBITORS | GILEAD SCIENCES, INC. (US) | 2024-12-04 | — | — | EP | disclosed |
| EP-4095133-B1 | BENZIMIDAZOLONE-BASED CINNAMAMIDE DERIVATIVE AS TRPV1 ANTAGONIST AND PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF PAIN CONTAINING SAME AS ACTIVE INGREDIENT | JMACKEM CO LTD (KR) | 2024-07-24 | — | — | EP | disclosed |
| CN-117355521-A | Heteroaryl inhibitors of plasma kallikrein | 武田药品工业株式会社 | 2024-01-05 | — | — | CN | disclosed |
| EP-0290145-A1 | Aliphatic carboxamides | ZENECA INC. (US) | 1988-11-09 | — | — | EP | disclosed |
| US-4729994-A | Benzothiazepine vasodilators having aralkyl substitution | MCNEILAB, INC. (US) | 1988-03-08 | — | — | US | disclosed |
| EP-0091883-B1 | PREEXTENSION CATALYSTS FOR EPOXY RESINS | CIBA-GEIGY AG (CH) | 1986-01-22 | — | — | EP | disclosed |
| US-4537964-A | Method of preparing permissibly-substituted 1H(and 2H)pyrazolo[3,4-g]quinolines; pyrimido[4,5,g]quinolines; thiazolo[4,5,g]quinolines and intermediates therefore | ELI LILLY AND COMPANY (US) | 1985-08-27 | — | — | US | disclosed |
| US-4499299-A | Pharmaceutically active phenylcarboxylic acid derivatives | ICI AMERICAS INC. (US) | 1985-02-12 | — | — | US | disclosed |
| US-4442099-A | Leukotriene analogues | RESEARCH CORPORATION (US) | 1984-04-10 | — | — | US | disclosed |
| EP-0091883-A1 | Preextension catalysts for epoxy resins | CIBA-GEIGY AG (CH) | 1983-10-19 | — | — | EP | disclosed |
| US-4125712-A | PROSTAGLANDINS | THE UPJOHN COMPANY (US) | 1978-11-14 | — | — | US | disclosed |
| US-4125713-A | PROSTAGLANDINS | THE UPJOHN COMPANY (US) | 1978-11-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250282722-A1 | 7-METHYL INDOLE ANALOGS AND DOSAGE FORMS CONTAINING THE SAME | HTR7, HTR2C, HTR1A | CA2 4598/4885CA4 4755/4885CA5A 4283/4885 |
| US-12441683-B2 | 7-methyl indole analogs and dosage forms containing the same | HTR7, HTR2C, HTR1A | CA2 4598/4885CA4 4755/4885CA5A 4283/4885 |
| US-12459922-B2 | PARP7 inhibitors | PARP1, PARP11, PARP2 | CA2 3900/4885CA4 3542/4885CA5A 1408/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.